Cargando…

Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5% at 5 years. From 2010, the Italian Association of Medical Oncology (AIOM) developed national guidelines for several cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silvestris, Nicola, Brunetti, Oronzo, Bittoni, Alessandro, Cataldo, Ivana, Corsi, Domenico, Crippa, Stefano, D’Onofrio, Mirko, Fiore, Michele, Giommoni, Elisa, Milella, Michele, Pezzilli, Raffaele, Vasile, Enrico, Reni, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352458/ https://www.ncbi.nlm.nih.gov/pubmed/32599886 http://dx.doi.org/10.3390/cancers12061681

Ejemplares similares

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020)

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM)
por: Orlacchio, Antonio, et al.
Publicado: (2022)

Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey
por: Zagonel, Vittorina, et al.
Publicado: (2016)

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)
por: Pedrazzoli, Paolo, et al.
Publicado: (2017)

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities
por: Moretti, Anna, et al.
Publicado: (2016)

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)
por: Salvatore, Lisa, et al.
Publicado: (2017)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
por: Azzariti, Amalia, et al.
Publicado: (2016)

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)
por: Di Maio, Massimo, et al.
Publicado: (2016)

Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
por: Conforti, F., et al.
Publicado: (2021)

MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
por: Natalicchio, A., et al.
Publicado: (2023)

The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective
por: Peretti, Umberto, et al.
Publicado: (2017)

ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary
por: Tarantini, Luigi, et al.
Publicado: (2017)

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
por: Longo, Vito, et al.
Publicado: (2016)

Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)
por: Caccialanza, Riccardo, et al.
Publicado: (2016)

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
por: Russo, A., et al.
Publicado: (2021)

Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
por: Gkountakos, Anastasios, et al.
Publicado: (2023)

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
por: Skorupan, Nebojsa, et al.
Publicado: (2023)

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)
por: Pedrazzoli, P., et al.
Publicado: (2022)

Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma
por: Lan, Xiaoyang, et al.
Publicado: (2023)

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)
por: Dieci, Maria Vittoria, et al.
Publicado: (2018)

Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
por: Silvestris, N., et al.
Publicado: (2021)

A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
por: Ferrara, Benedetta, et al.
Publicado: (2022)

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
por: Orsi, G., et al.
Publicado: (2021)

Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
por: Gallo, M., et al.
Publicado: (2021)

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
por: Pedrazzoli, P., et al.
Publicado: (2023)

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
por: Argentiero, Antonella, et al.
Publicado: (2019)

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
por: Moore, P S, et al.
Publicado: (2001)

Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis
por: Quilichini, Evans, et al.
Publicado: (2019)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
por: Argentiero, Antonella, et al.
Publicado: (2019)

COVID Vaccination in Cancer Patients: What Vaccination Priority Strategies Should There Be?
por: Silvestris, Nicola, et al.
Publicado: (2021)

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Pezzilli, Raffaele, et al.
Publicado: (2015)

Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer
por: Lafranceschina, Stefano, et al.
Publicado: (2019)

CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas
por: D’Onofrio, Mirko, et al.
Publicado: (2021)

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
por: Silvestris, N., et al.
Publicado: (2021)

Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
por: Reni, M., et al.
Publicado: (2023)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
por: Procaccio, Letizia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4r9gl0lujo464p4bqso271jdis